Intellectual Property

IP Title Country(s) Status Publication No.
Polypeptide Fragments, Immunogenic Composition Against Influenza Virus, And Implementations Thereof United States, European Patent Office Registered US20170204142A1, EP3137487B1
A Method Of Residue Proximity Information And Protein Model Discrimination Using Saturation-Suppressor Mutagenesis United States, European Patent Office, Spain Registered US11639500B2, EP3384075B1, ES2961557T3
Polypeptides For Generating Anti-Influenza Antibodies And Uses Thereof United States, European Patent Office, South Africa Granted US10344058B2, EP3137487B1
Mapping Protein Binding Sites And Conformational Epitopes Using Cysteine Labelling And Surface Display Library European Patent Office Registered EP3552023B1
Polypeptide Fragments, Immunogenic Composition Against SARS-CoV-2, And Implementations Thereof United States, European Patent Office Registered US20240262869A1, EP4175667A2
Polypeptide Fragments, Immunogenic Composition Against Influenza Virus, And Implementations Thereof United States, European Patent Office, Australia, Indonesia, Malaysia, Philippines, Vietnam Registered US20250325649A1, EP4456915A4, AU2022425707A1
Stabilized Immunogens Derived From Spike Of Coronavirus, Compositions And Methods Thereof Patent Cooperation Treaty (PCT) Registered WO2024157279A1
Hemagglutinin Based Immunogenic Polypeptides, Compositions And Methods Thereof Patent Cooperation Treaty (PCT) Registered WO2026069378A1
Immunogenic Polypeptides And Vaccine Compositions Against Diverse Sarbecoviruses India Granted IN598824B1
Disulphide-Linked Oligomerization Domain, Polypeptides, And Uses Thereof Patent Cooperation Treaty (PCT) Registered WO2026083454A1

Countries, statuses, and publication numbers are presented in corresponding order.